Who was Barbara Mitchell?
  1. Access to Drugs
  2. Access to Drugs

Access to Drugs

Janvier 19, 2018 1:56PM

Ottawa’s revisions to drug-pricing review board will delay or prevent access to new drugs
Dr. Nigel Rawson
Printer-friendly version

Pharmaceutical manufacturers take on a significant investment risk to develop new drugs.

Étiquettes:
drug costs, prescription drug costs, Access to Drugs, patented drugs